These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 20713906

  • 1. Letter by Violi et al regarding article, "Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization".
    Violi F, Pignatelli P, Basili S.
    Circulation; 2010 Aug 17; 122(7):e429; author reply e430. PubMed ID: 20713906
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE.
    Circulation; 2006 Jun 27; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Aspirin resistance and atherothrombotic disease.
    Maree AO, Jneid H, Fitzgerald DJ.
    J Am Coll Cardiol; 2006 Aug 15; 48(4):846-7; author reply 847. PubMed ID: 16904562
    [No Abstract] [Full Text] [Related]

  • 11. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
    Bondar' TN, Kravchenko NA.
    Tsitol Genet; 2012 Aug 15; 46(4):66-72. PubMed ID: 23074965
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aspirin resistance: does it exist and is it an important clinical problem?
    Eikelboom J.
    Clin Adv Hematol Oncol; 2006 Apr 15; 4(4):268-70. PubMed ID: 16728937
    [No Abstract] [Full Text] [Related]

  • 14. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
    Ben-Dor I, Kleiman NS, Lev E.
    Am J Cardiol; 2009 Jul 15; 104(2):227-33. PubMed ID: 19576352
    [Abstract] [Full Text] [Related]

  • 15. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.
    Am J Cardiol; 2008 Aug 15; 102(4):396-400. PubMed ID: 18678294
    [Abstract] [Full Text] [Related]

  • 16. Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings.
    Crescente M, Cerletti C, de Gaetano G.
    Thromb Haemost; 2007 Jun 15; 97(6):1054-6. PubMed ID: 17549313
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM.
    Platelets; 2005 Aug 15; 16(5):269-80. PubMed ID: 16011977
    [Abstract] [Full Text] [Related]

  • 18. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ, Bernardo E, Sabaté M, Jimenez-Quevedo P, Costa MA, Palazuelos J, Hernández-Antolin R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Guzman LA, Bass TA, Macaya C, Fernandez-Ortiz A.
    J Am Coll Cardiol; 2007 Oct 16; 50(16):1541-7. PubMed ID: 17936152
    [Abstract] [Full Text] [Related]

  • 19. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW, Topcu Y, Postma S, Kelder JC, Hackeng CM, ten Berg JM, Verheugt FW.
    Thromb Haemost; 2008 Mar 16; 99(3):637-9. PubMed ID: 18327417
    [No Abstract] [Full Text] [Related]

  • 20. Platelet function monitoring in patients with coronary artery disease.
    Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1822-34. PubMed ID: 17980247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.